Instrument Inactif

Communiqués Lifecare AS Oslo Bors

Actions

NO0010591191

Recherche biotechnologique et médicale

Communiqués

02/07	LIFE: Update on production transfer and longevity programme	AQ
26/06	LIFE: Operational update regarding Lifecare Germany GmbH (i.L)	PU
22/06	LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation	AQ
12/06	Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue	PU
10/06	Lifecare ASA: Mandatory notification of trade	PU
10/06	Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response	AQ
01/06	Lifecare ASA: Commencement of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue	PU
19/05	Lifecare ASA: Mandatory notification of trade	PU
19/05	Lifecare ASA: Mandatory notification of trade	PU
15/05	Lifecare : Interim Report Q1 2026 Presentation	PU
07/05	Lifecare ASA (LIFE): Invitation to Q1 2026 results presentation	AQ
23/04	Lifecare : Annual General Meeting minutes	PU
01/04	Lifecare : Annual General Meeting	PU
01/04	Lifecare : Annual General Meeting	PU
01/04	Lifecare : Annual Report 2025	PU
01/04	Lifecare : Remuneration Report 2025	PU
01/04	Disclosure of shareholding	AQ
13/03	Lifecare : Chief Scientific Officer to step down from executive role	PU
13/03	Lifecare ASA: Mandatory notification of trade	PU
11/03	Lifecare ASA: Mandatory notification of trade	PU
09/03	Lifecare ASA: Mandatory notification of trade	PU
05/03	Lifecare ASA: Mandatory notification of trade	PU
03/03	Lifecare : Year-end Report Q4 2025 Presentation	PU
02/03	Lifecare ASA: Commencement of the Exercise Period for Warrants Series 1 issued in connection with the Rights Issue	PU
27/02	Lifecare ASA: Exercise price for Warrants Series 1 issued in connection with the Rights Issue	PU